secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001174947-24-000582
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q1 2024: revenue up 5.7% to $312.3M; adjusted EPS $0.79 beats; guidance trimmed on FX headwinds
--------------------------------------------------------------------------------

- GAAP diluted EPS $0.63 vs $0.06 in Q1 2023; adjusted EPS $0.79, up 19.7% YoY.
- Revenue $312.3M (+5.7% as reported, +5.9% constant currency); domestic +7.2%, international +3.8%.
- General Surgery revenue grew 8.0% as reported; Orthopedic Surgery +2.8%.
- FY2024 revenue guidance lowered to $1.330-1.355B (prev $1.340-1.365B) due to ~$10M FX headwind.
- Adjusted EBITDA $56.3M, margin 18.0% vs 17.3% in Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494724000582/0001174947-24-000582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494724000582/form8k-32144_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-24-000582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer